Missing Data – A Common But Critical Issue in Clinical Studies In part one, of this two part blog series, we will discuss the missing data issue in clinical studies. In bioavailability (BA) and bioequivalence (BE) studies with pharmacokinetic endpoints, the occurrence...
This blog unfolds the varied journeys of three individuals at BioPharma Services, each narrating their unique experience in the clinical research landscape. From the initial steps as interns to evolving into Clinical Research Coordinators, their stories reflect the...
In a world where our beginnings often predetermine our paths, my story is a testament to the power of perseverance, adaptability, and an unyielding commitment to excellence. Born into the confines of traditional Chinese customs, my journey has been about challenging...
Every successful Clinical Research Organization (CRO), whether a small startup or a large corporation, relies heavily on the support and collaboration of sponsors. These CRO sponsors serve a crucial role by offering not only financial backing but also valuable...
Designing efficient and safe clinical trials that generate reliable and accurate data is indispensable for the success of clinical drug development programs. Even though randomized, double-blind clinical trials, which reduce the risk of bias, are a preferred clinical...
Global medicine spending is projected to be significantly increased close to 2 trillion by 2027 with the annual increase rate from 3 to 6%. And that figure excludes the impact of COVID-19 therapeutics and vaccines. The therapeutics areas with the highest projected...
